Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Studies in Health Technology and Informatics|January 22, 2022
An Evaluation of Pretrained BERT Models for Comparing Semantic Similarity Across Unstructured Clinical Trial TextsJessica Patricoski, Kory Kreimeyer, Archana Balan, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
Reconstructing clone-resolved transcriptional programs from bulk tumor sequencingJiaying Lai, Yi Yang, Kathleen Noller, et al.
Frontiers in Medicine|December 25, 2023
Druggable genomic landscapes of high-grade gliomasPaola Ghanem, Maria Fatteh, David Olayinka Kamson, et al.
JCO Clinical Cancer Informatics|April 11, 2023
Precision Oncology Core Data Model to Support Clinical Genomics Decision MakingTaxiarchis Botsis, Joseph C Murray, Paola Ghanem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2023
Dynamics of Sequence and Structural Cell-Free DNA Landscapes in Small-Cell Lung CancerLavanya Sivapalan, Wade T Iams, Zineb Belcaid, et al.
Frontiers in Oncology|August 22, 2022
Sex-specific differences in immunogenomic features of response to immune checkpoint blockadeSusan C Scott, Xiaoshan M Shao, Noushin Niknafs, et al.
Cancer Research Communications|October 29, 2024
SpliceMutr Enables Pan-Cancer Analysis of Splicing-Derived Neoantigen Burden in TumorsTheron Palmer, Michael D Kessler, Xiaoshan M Shao, et al.
Nature Cancer|July 22, 2025
Combination of pembrolizumab and radiotherapy induces systemic antitumor immune responses in immunologically cold non-small cell lung cancerJustin Huang, Willemijn S M E Theelen, Zineb Belcaid, et al.
Cancer Research Communications|April 19, 2026
Serial Plasma Comprehensive Genomic Profiling Captures Therapy Resistance and Guides Management of Non-Small Cell Lung CancerMichael Conroy, Jaime Wehr, Vivian V Altiery De Jesus, et al.
Communications Medicine|February 6, 2026
Pembrolizumab and epigenetic modification with azacitidine reshapes the tumor microenvironment of platinum-resistant epithelial ovarian cancer: a phase 2 non-randomized clinical trialBlair V Landon, Julia L Boland, Andrea E Wahner Hendrickson, et al.
Pageof 2